TUMORANTIGENPEPTIDE
European patent · EP3199627 · Deleted
Register entry
- Publication number
- EP3199627
- Application number
- EP15843390
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Sep 24, 2015
- Published
- Aug 2, 2017
- Granted
- Apr 7, 2021
- Deleted
- Apr 29, 2022
- Reason
- Annual fee unpaid
- IPC classes
- C12N 15/00 (2006.01)A61K 35/76 (2015.01)A61K 39/00 (2006.01)A61K 48/00 (2006.01)A61P 35/00 (2006.01)A61P 37/04 (2006.01)C07K 7/06 (2006.01)C12N 5/10 (2006.01)C12N 15/09 (2006.01)C07K 14/82 (2006.01)
- Priority
- JP 2014194391 24.09.2014
- PCT application
- PCT/JP2015/076994 24.09.2015
- PCT publication
- WO2016/047715 31.03.2016
- Filing language
- Japanese
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Apr 29, 2022
Deleted, fee unpaid
Published in Swissreg on 29.04.2022
- Feb 16, 2022
Change
Published in Swissreg on 16.02.2022
- Apr 7, 2021
Granted
Published in Swissreg on 07.04.2021
Parties
Holder
Inventor
Sapporo-shi Hokkaido 060-8556, JP
Sapporo-shi Hokkaido 060-8556, JP
Ina Nagano 396-0002, JP
Sapporo-shi Hokkaido 060-8556, JP
Ina Nagano 396-0002, JP
Ina Nagano 396-0002, JP
Ina Nagano 396-0002, JP
Sapporo-shi Hokkaido 060-8556, JP
Ina Nagano 396-0002, JP
Sapporo-shi Hokkaido 060-8556, JP
Sapporo-shi Hokkaido 060-8556, JP
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.